TY - JOUR
T1 - Screening for Cushing Syndrome at the Primary Care Level
T2 - What Every General Practitioner Must Know
AU - Yorke, Ernest
AU - Atiase, Yacoba
AU - Akpalu, Josephine
AU - Sarfo-Kantanka, Osei
N1 - Publisher Copyright:
© 2017 Ernest Yorke et al.
PY - 2017
Y1 - 2017
N2 - Cushing's syndrome is a rare entity, and a high index of suspicion is needed for screening in a primary care setting. The clinical awareness of the primary care physician (PCP) to the highly indicative signs and symptoms such as facial plethora, proximal myopathy, reddish purple striae, and easy bruisability should alert him to look for biochemical evidence of Cushing's syndrome through any of the first-line screening tests, namely, 24-hour urinary free cortisol, overnight dexamethasone suppression test, or late-night salivary cortisol. Commonly used random cortisol measurements are unreliable; hence, general practitioners are encouraged to understand the use of these more reliable tests with increased sensitivity and specificity for screening Cushing's syndrome. In this write-up, we set out to increase awareness about the presentation of Cushing's syndrome and current recommended screening methods as well as their strengths and weaknesses. We relied mainly on the recommendations by the Endocrine Society Guidelines.
AB - Cushing's syndrome is a rare entity, and a high index of suspicion is needed for screening in a primary care setting. The clinical awareness of the primary care physician (PCP) to the highly indicative signs and symptoms such as facial plethora, proximal myopathy, reddish purple striae, and easy bruisability should alert him to look for biochemical evidence of Cushing's syndrome through any of the first-line screening tests, namely, 24-hour urinary free cortisol, overnight dexamethasone suppression test, or late-night salivary cortisol. Commonly used random cortisol measurements are unreliable; hence, general practitioners are encouraged to understand the use of these more reliable tests with increased sensitivity and specificity for screening Cushing's syndrome. In this write-up, we set out to increase awareness about the presentation of Cushing's syndrome and current recommended screening methods as well as their strengths and weaknesses. We relied mainly on the recommendations by the Endocrine Society Guidelines.
UR - http://www.scopus.com/inward/record.url?scp=85027269847&partnerID=8YFLogxK
U2 - 10.1155/2017/1547358
DO - 10.1155/2017/1547358
M3 - Review article
AN - SCOPUS:85027269847
SN - 1687-8337
VL - 2017
JO - International Journal of Endocrinology
JF - International Journal of Endocrinology
M1 - 1547358
ER -